| Similar Articles |
|---|
 |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape.   |
Pharmaceutical Executive
August 1, 2013 |
Country Report: Denmark and Sweden On the Northern fringes of Europe, those who want to believe that there is a sustainable future for the old continent's generous healthcare systems find a beacon of hope. |
Pharmaceutical Executive
April 10, 2014
Christini & Kaitin |
Regional Trends in Bioinnovation Investment Can the Cambridge model be duplicated? |
Chemistry World
November 13, 2014
Waldemar Ingdahl |
Sweden pushes for research to boost industry Stefan Lofven heads up the new Swedish government, which wants research and industry to work together more closely. |
Bio-IT World
June 15, 2003
Melissa Kruse |
Midwest/South Region Ohio: Outpacing U.S. in Bioscience Growth... Alabama: Sweet Home to Tech Tax Incentives... Kentucky: Investing Multimillions to Breed Bio Business... Minnesota: The 'Right Mix' of Talent and Funding... Tennessee: Pioneering Research Centers... Michigan: Teeming 'Life Sciences Corridor'... etc. |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
Inc.
May 1, 2002
Kenneth Klee |
The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies... |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
Reason
January 2003
Brian Doherty |
Vouching for Vouchers School choice in Sweden: A new study by two Swedish economists examines whether the Swedish voucher program has hurt education in public schools. |
Bio-IT World
February 2006
G. Steven Burrill |
Outlook for '06, Look Back at '05 Overall, 2005 turned out to be an exceptional year for the biotech industry, but it wasn't all good news: Look Back at 2005... Predictions for 2006... |
Pharmaceutical Executive
October 1, 2011 |
Sweden: Setting the Pace for Global Pharma On health system decentralization, regulatory convergence, drug detailing, promotion, patient information, the environment, value-based pricing, and the pursuit of cost-effectiveness, the Nordics have been true innovators over the past decades. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Northwest Region Colorado: Biotech Summit in Denver... Utah: A Mecca for Genealogical Research... Washington State: Therapeutics and Diagnostics Niche... |
The Motley Fool
December 14, 2004
Charly Travers |
Genetics of a Rule Breaker Investing is a lifelong learning process. We never know everything, but it is important we strive to learn from the lumps we take along the way. Here are some hard-earned tips from a biotech investor. |
BusinessWeek
June 13, 2005
Arlene Weintraub |
Why Biotech Stocks Are Sedated Biotech might seem like a can't-miss investing opportunity but many investors are taking a pass on biotech, even amid bona fide scientific advances. |
National Defense
October 2007
Lawrence P. Farrell |
Energy: `One Big Thing' Having spent nearly a year a half in Sweden, U.S. Ambassador to Sweden Michael M. Wood has had the opportunity to see what the Swedes have been doing about energy. He finds much to applaud. |
Chemistry World
February 2008
Nuala Moran |
The Chemistry of Private Equity Private equity has transformed the chemicals industry, but can it play the same role in high-risk R&D driven companies? |
The Motley Fool
January 28, 2011
Luke Timmerman |
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars Biotech drugs will soon dominate the pharmaceutical industry, and Merck is playing catch-up. |
IndustryWeek
October 1, 2001
Tom Mudd |
Bridge To Bilateralism? Despite high expectations and potential, The Oresund Bridge linking Denmark and Sweden has been a disappointment to date... |
BusinessWeek
June 16, 2011
Brendan Greeley |
How Sweden Steered Clear of the Greece Fiasco The case for national sovereignty: By staying out of the euro, the Swedes have steered clear of Greece's mess. Brussels, take note. |
The Motley Fool
August 18, 2010
Travers & Jayson |
The Most Important Thing About Human Genome Sciences Is Human Genome Sciences on strong financial footing? Take a look. |
The Motley Fool
January 29, 2007
Jack Uldrich |
Sweden Takes Off Second Life and space initiatives are both strategic moves. Investors, keep your eyes on the Swedes; they could be up to something -- and it could burn you if you're not careful. |
The Motley Fool
April 4, 2005
John Reeves |
Returns That Defy the Imagination Want to save lives while pursuing a high-growth investment strategy? Try exploring the biotech frontier. |
BusinessWeek
March 7, 2005
Arlene Weintraub |
Where VCs Fear To Tread Angel investors are filling a critical gap by providing early backing for biotechs. |
The Motley Fool
July 14, 2011
Rich Smith |
What's All the Fuss About Stem Cells? Stocks are up on news of Sweden's miracle meatball. Over the weekend, Swedish researchers announced the successful transplant of an artificial trachea to a patient whose own organ had been ravaged by cancer. |
BusinessWeek
September 29, 2003
Stanley Reed |
A Blow to the Euro? Sweden's "no" vote may alter the path of EU integration. |
BusinessWeek
August 4, 2003
Reed & Sains |
What'll It Be, Sweden? Its September vote on adopting the euro has the nation on edge |
BusinessWeek
March 13, 2008
Reed & Sains |
The Stockholm Solution We can learn some important lessons from Sweden's response to its 1991 credit crisis. |
The Motley Fool
January 25, 2005
Charly Travers |
Grading Old-School Biotech Be very wary of biotech IPOs from companies lacking drugs. |
BusinessWeek
July 12, 2004
Kerry Capell |
These Biotechs Need Time To Ripen A rush to the IPO market in Europe won't do the biotech industry any good. |
BusinessWeek
June 24, 2010
Simmons & Magnusson |
Cristina Stenbeck of Sweden's Kinnevik The American-born head of Sweden's second-largest family investment firm has managed the empire she inherited by steering a careful course. |
BusinessWeek
September 16, 2010
Carlstrom & Brogger |
At Election Time, Sweden Looks Less Socialist Reinfeldt's Moderate Party is popular, and may continue its lower-tax, lower-welfare agenda |
National Defense
September 2005
Robert H. Williams |
Advanced Armor Weapon Receives Killer Eyes Sweden's Bofors Dynamics has chosen Trijicon to produce magnified combat optics for its new lightweight antitank weapon that is being acquired by British and Swedish ground forces. |
